Picard Medical, Inc.
Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the USA, Europe, and internationally. The compa… Read more
Picard Medical, Inc. (PMI) - Net Assets
Latest net assets as of September 2025: $7.97 Million USD
Based on the latest financial reports, Picard Medical, Inc. (PMI) has net assets worth $7.97 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.52 Million) and total liabilities ($5.55 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $7.97 Million |
| % of Total Assets | 58.93% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Picard Medical, Inc. - Net Assets Trend (2022–2024)
This chart illustrates how Picard Medical, Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Picard Medical, Inc. (2022–2024)
The table below shows the annual net assets of Picard Medical, Inc. from 2022 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-23.74 Million | -568.24% |
| 2023-12-31 | $-3.55 Million | -131.24% |
| 2022-12-31 | $11.37 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Picard Medical, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3662400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.00K | % |
| Other Comprehensive Income | $278.00K | % |
| Other Components | $25.83 Million | % |
| Total Equity | $-23.74 Million | 100.00% |
Picard Medical, Inc. Competitors by Market Cap
The table below lists competitors of Picard Medical, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BeWhere Holdings Inc
OTCQB:BEWFF
|
$30.33 Million |
|
Galway Metals Inc
OTCQB:GAYMF
|
$30.34 Million |
|
Growthpoint Properties Ltd
JSE:GRT
|
$30.34 Million |
|
Electrotherm (India) Limited
NSE:ELECTHERM
|
$30.34 Million |
|
Camil Alimentos S.A
SA:CAML3
|
$30.31 Million |
|
Royal Orchid Hotels Limited
NSE:ROHLTD
|
$30.30 Million |
|
RetinalGenix Technologies Inc
OTCQB:RTGN
|
$30.27 Million |
|
SMC Investment Trading JSC
VN:SMC
|
$30.26 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Picard Medical, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -3,552,000 to -23,736,000, a change of -20,184,000.
- Net loss of 21,055,000 reduced equity.
- Other comprehensive income decreased equity by 15,000.
- Other factors increased equity by 886,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-21.05 Million | -88.7% |
| Other Comprehensive Income | $-15.00K | -0.06% |
| Other Changes | $886.00K | +3.73% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Picard Medical, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | $0.16 | $1.16 | x |
| 2023-12-31 | $-0.05 | $1.16 | x |
| 2024-12-31 | $-0.33 | $1.16 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Picard Medical, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -479.50%
- • Asset Turnover: 0.36x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-32.74%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -98.23% | -271.53% | 0.27x | 1.36x | $-12.30 Million |
| 2023 | 0.00% | -308.72% | 0.44x | 0.00x | $-15.21 Million |
| 2024 | 0.00% | -479.50% | 0.36x | 0.00x | $-18.68 Million |
Industry Comparison
This section compares Picard Medical, Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $498,972,584
- Average return on equity (ROE) among peers: -54.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Picard Medical, Inc. (PMI) | $7.97 Million | -98.23% | 0.70x | $30.32 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-2.23 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $187.53 Billion |
| Acarix AB (publ) (ACIXF) | $51.88 Million | -150.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $3.82 Million |
| Adm Tronics Unltd (ADMT) | $644.00K | 0.00% | 0.66x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $6.03 Million | -94.15% | 0.22x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $75.02 Million | -52.81% | 0.78x | $732.88K |
| Adapthealth Corp (AHCO) | $24.31K | -2.84% | 11.78x | $916.00 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $8.41 Million |